Literature DB >> 26546360

Lack of CD2AP disrupts Glut4 trafficking and attenuates glucose uptake in podocytes.

Tuomas A Tolvanen1, Surjya Narayan Dash1, Zydrune Polianskyte-Prause1, Vincent Dumont1, Sanna Lehtonen2.   

Abstract

The adapter protein CD2-associated protein (CD2AP) functions in various signaling and vesicle trafficking pathways, including endosomal sorting and/or trafficking and degradation pathways. Here, we investigated the role of CD2AP in insulin-dependent glucose transporter 4 (Glut4, also known as SLC2A4) trafficking and glucose uptake. Glucose uptake was attenuated in CD2AP(-/-) podocytes compared with wild-type podocytes in the basal state, and CD2AP(-/-) podocytes failed to increase glucose uptake in response to insulin. Live-cell imaging revealed dynamic trafficking of HA-Glut4-GFP in wild-type podocytes, whereas in CD2AP(-/-) podocytes, HA-Glut4-GFP clustered perinuclearly. In subcellular membrane fractionations, CD2AP co-fractionated with Glut4, IRAP (also known as LNPEP) and sortilin, constituents of Glut4 storage vesicles (GSVs). We further found that CD2AP forms a complex with GGA2, a clathrin adaptor, which sorts Glut4 to GSVs, suggesting a role for CD2AP in this process. We also found that CD2AP forms a complex with clathrin and connects clathrin to actin in the perinuclear region. Furthermore, clathrin recycling back to trans-Golgi membranes from the vesicular fraction containing GSVs was defective in the absence of CD2AP. This leads to reduced insulin-stimulated trafficking of GSVs and attenuated glucose uptake into CD2AP(-/-) podocytes.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Actin; Clathrin; GGA2; Glut4 trafficking

Mesh:

Substances:

Year:  2015        PMID: 26546360     DOI: 10.1242/jcs.175075

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

Review 1.  Single-molecule labeling for studying trafficking of renal transporters.

Authors:  Ankita Bachhawat Jaykumar; Paulo S Caceres; Pablo A Ortiz
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-25

2.  SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.

Authors:  Paola Cassis; Monica Locatelli; Domenico Cerullo; Daniela Corna; Simona Buelli; Cristina Zanchi; Sebastian Villa; Marina Morigi; Giuseppe Remuzzi; Ariela Benigni; Carlamaria Zoja
Journal:  JCI Insight       Date:  2018-08-09

3.  PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease.

Authors:  Vincent Dumont; Tuomas A Tolvanen; Sara Kuusela; Hong Wang; Tuula A Nyman; Sonja Lindfors; Jukka Tienari; Harry Nisen; Shiro Suetsugu; Markus Plomann; Hiroshi Kawachi; Sanna Lehtonen
Journal:  FASEB J       Date:  2017-05-26       Impact factor: 5.191

Review 4.  Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?

Authors:  Anita A Wasik; Sanna Lehtonen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-09       Impact factor: 5.555

5.  BioID identifies proteins involved in the cell biology of caveolae.

Authors:  C Mendoza-Topaz; I Yeow; K Riento; B J Nichols
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

6.  Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.

Authors:  Zydrune Polianskyte-Prause; Tuomas A Tolvanen; Sonja Lindfors; Vincent Dumont; Mervi Van; Hong Wang; Surjya N Dash; Mika Berg; Jette-Britt Naams; Laura C Hautala; Harry Nisen; Tuomas Mirtti; Per-Henrik Groop; Kristiina Wähälä; Jukka Tienari; Sanna Lehtonen
Journal:  FASEB J       Date:  2018-10-15       Impact factor: 5.834

Review 7.  The role of CD2AP in the Pathogenesis of Alzheimer's Disease.

Authors:  Qing-Qing Tao; Yu-Chao Chen; Zhi-Ying Wu
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

8.  Novel Sulfonanilide Inhibitors of SHIP2 Enhance Glucose Uptake into Cultured Myotubes.

Authors:  Mika E A Berg; Jette-Britt Naams; Laura C Hautala; Tuomas A Tolvanen; Jari P Ahonen; Sanna Lehtonen; Kristiina Wähälä
Journal:  ACS Omega       Date:  2020-01-14

Review 9.  SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.

Authors:  Sanna Lehtonen
Journal:  Acta Physiol (Oxf)       Date:  2019-08-12       Impact factor: 6.311

10.  Exogenous spermine attenuates diabetic kidney injury in rats by inhibiting AMPK/mTOR signaling pathway.

Authors:  Xinying Zhang; Li Zhang; Zhe Chen; Siwei Li; Bingbing Che; Ningning Wang; Junting Chen; Changqing Xu; Can Wei
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.